More compact doses for perioral treatment than for upper facial programs are used because the oral musculature responds much more strongly to the identical BTX-A dosing. Just one preparation of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indicator and FDA approval lies in treatments of cervical dystonia. In https://botulinum-toxins39506.mybjjblog.com/the-ultimate-guide-to-botulinum-toxins-in-humans-48145163